DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Greten TF, Ormandy LA, Fikuart A et al.
Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC.
J Immunother 2010;
33: 211-218
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.